BFS Molecular

BFS Molecular Offers a New Post-Transplant Monitoring Test, Providing New Methods and Higher-Quality Results. Early Detection of Adverse Events Gives Doctors More Treatment Options, Potentially Avoiding Transplant Rejection or Disease Recurrence. This Will Improve the Prognosis for Many Transplant Patients and Save Significant Costs for National Health Agencies and Insurance Companies.